Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Compare diversification outcomes of common stock index options in retirement planning, highlighting practical considerations.
25,636 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A senior House Democrat is pressing the Federal Reserve Bank of Kansas City for full details on Kraken’s master accou...
If Spirit faces liquidation, the fleet faces a multi-step journey from repossession to resale. Here's a concise brief...
Markets react to a surprising Air Force One seat allocation featuring Nvidia’s CEO, sparking chatter that export lice...
A two-week surge from late April to mid-May 2026 rewired listing data, with private networks expanding and major brok...
Three leading space names moved higher in a risk-on trading session, with AST SpaceMobile, Rocket Lab and Planet Labs...
A looming base oil shortage threatens routine oil changes as global supply tightens. The ‘imminent’ crisis isn’t pump...
A sweeping crypto downturn sparks roughly $1.2 billion in liquidations, as Ethereum tests key support under $1.7K and...
Inflation data for May shows a 4.2% year-over-year rise, sparking notable moves in bitcoin (btc) price moves. Traders...
Senator Lummis frames Bitcoin as a hedge against mounting U.S. debt as the CLARITY Act moves closer to a Senate floor...
Cardano’s founder positions AI agents as essential infra for Midnight City, while ADA hovers near $0.16 as traders we...
AI-driven data centers are reshaping memory supply. This article breaks down what data centers will consume for memor...